Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$161.01 - $317.85 $1.19 Million - $2.35 Million
7,398 Added 26.8%
35,000 $11.1 Million
Q3 2023

Nov 14, 2023

BUY
$164.66 - $218.08 $3.69 Million - $4.88 Million
22,397 Added 430.3%
27,602 $4.67 Million
Q2 2023

Aug 14, 2023

BUY
$176.32 - $240.22 $917,745 - $1.25 Million
5,205 New
5,205 $1.13 Million
Q4 2022

Feb 14, 2023

SELL
$191.53 - $236.82 $8.24 Million - $10.2 Million
-43,043 Reduced 74.54%
14,701 $2.89 Million
Q3 2022

Nov 14, 2022

BUY
$123.79 - $277.42 $7.15 Million - $16 Million
57,744 New
57,744 $13 Million
Q4 2021

Feb 14, 2022

SELL
$110.64 - $159.4 $815,638 - $1.18 Million
-7,372 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$101.2 - $125.87 $1.05 Million - $1.3 Million
-10,345 Reduced 58.39%
7,372 $902,000
Q2 2021

Aug 16, 2021

SELL
$107.45 - $135.95 $1.5 Million - $1.9 Million
-13,981 Reduced 44.11%
17,717 $2.02 Million
Q1 2021

May 17, 2021

SELL
$95.46 - $133.08 $1.87 Million - $2.61 Million
-19,575 Reduced 38.18%
31,698 $3.81 Million
Q4 2020

Feb 16, 2021

BUY
$75.23 - $109.23 $233,589 - $339,159
3,105 Added 6.45%
51,273 $5.21 Million
Q3 2020

Nov 16, 2020

BUY
$71.31 - $109.74 $864,277 - $1.33 Million
12,120 Added 33.62%
48,168 $3.72 Million
Q2 2020

Aug 14, 2020

BUY
$62.14 - $117.21 $2.24 Million - $4.23 Million
36,048 New
36,048 $4.02 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.